baber/WOPTO huggingface dataset:
Patent CA-2461533-A1 (CA)
Title: A method, a device, and a system for organ reconditioning and a device for preserving an internal bodyorgan
Inventor: SOLEM JAN OTTO
IPC: A61B17/00
Filed: 2002-09-20
Abstract: A device for reconditioning an internal bodyorgan having or risking a functional failure or impairment associated with a fluid collection therein comprises a tube having a proximal end adapted for connection to a vacuum source, and a distal end portion having a plurality of openings. A chamber surrounds the distal end portion of the tube and the openings the rein. A flexible material occupies said chamber and forms fluid connections between a selected part of an external surface of the chamber and the openings of the distal end portion of the tube. The selected part of the external surface of the chamber is adapted for contacting an external or internal surface portio n of the internal body organ. Thereby, interstitial fluid of the internal body organ adjoining said selected part of the external surface of the chamber is sucked off from the internal body organ.
Patent CA-2461637-A1 (CA)
Title: Rear alignment and support system for a cooking appliance cooktop
Inventor: BRIEDIS VAL
IPC: F24C7/08
Filed: 2004-03-22
Abstract: A cooking appliance includes a cabinet, defined by at least front, side, bottom and back panel portions, a pair of laterally spaced end caps provided at an upper rear portion cabinet, and a range top mounted upon an upper portion of the cabinet. At least two sets of alignment components, with each set of alignment components being defined by cooperating first and second sets of alignment elements, are provided on the end caps and range top respectively. When the range top is mounted upon the cabinet, the sets of alignment components become interengaged to automatically, laterally center and mount the range top with respect to the cabinet.
Patent CA-2463287-A1 (CA)
Title: Beta-ketophosphonates
Inventor: SMITH ALAN CRAIG
IPC: C07F9/40
Filed: 2002-08-23
Abstract: In a method for making .beta.-ketophosphonates by reacting a trialkyl phosphonocarboxylate (such as triethyl phosphonoacetate) with an acyl halide (such as acetyl chloride) in a reaction involving ester formation, followed by decarboxylation, followed by purification, the improvement which comprises carrying out the reaction in a single solvent, which is not removed from the reaction mixture until the purification stage. Suitable solvents for this purpose include halogenated aromatic hydrocarbons (such as mono-chlorobenzen e).
Patent CA-2464920-A1 (CA)
Title: Procede permettant d'augmenter la vitesse de polymerisation a l'etat solide de polymeres polyester
Inventor: PARTHASARATHY ANJU
IPC: C08G/
Filed: 2002-12-18
Abstract: L'invention concerne un procédé permettant d'augmenter la vitesse de polymérisation de polymères polyester à l'état solide et consistant à ajouter une quantité catalytique de p-toluènesulfonate de zinc dans des polymères polyester fondus sensiblement exempts d'antimoine et de germanium, avant la polymérisation à l'état solide.
Patent CA-2466780-A1 (CA)
Title: Preparation of ionic liquids
Inventor: ROBERTSON ALLAN J
IPC: C07C309/04
Filed: 2002-12-13
Abstract: Provided is a method for preparation of non-halide based ionic liquids, comprising reacting a halide salt of an organic cation with a Bronsted acid in the presence of an alcohol or alkene or alkyne. The non-halide based ionic liquid product of the reaction can be purified by removing hydrocarbyl halide, and any unreacted starting materials and water if present, for example by distillation. The halide ion content of the ionic liquid product can be minimized by using an excess of alcohol or alkene or alkyne in the reaction and/or treating crude ionic liquid with a further quantity of alcohol or alkene or alkyne.
Patent CA-2469282-A1 (CA)
Title: Procede, application logicielle et systeme permettant de fournir des donnees reperes
Inventor: FLECKENSTEIN THOMAS
IPC: G06F40/143
Filed: 2003-02-13
Abstract: Publié sans précis
Patent CA-2470480-A1 (CA)
Title: Indolinone derivatives useful as protein kinase inhibitors
Inventor: WRAY JONATHAN W
IPC: A61P35/00
Filed: 2002-12-20
Abstract: Compounds of formula (I) in which R1, R2, R3 and R4 have the meanings given in the specification, are receptor tyrosine kinase inhibitors useful in the treatment of proliferative disorders, such as cancer.
Patent CA-2470668-A1 (CA)
Inventor: AUBERT JEROME
IPC: A61P1/00
Filed: 2002-12-20
Abstract: Cette invention concerne une composition pharmaceutique solide destinée à être administrée par voie oral, laquelle composition renferme jusqu'à 10 % en poids de tegaserod sous forme basique ou saline, entre 70 et 90 % en poids d'un agent diluant, une quantité inférieure ou égale à 15 % en poids d'un délitant ainsi qu'un agent de glissement et un lubrifiant.
Patent CA-2472882-A1 (CA)
Inventor: BATTERHAM RACHEL LOUISE
IPC: A61K38/17
Filed: 2003-01-10
Abstract: Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering PYY or an agonist thereof and GLP-1 or an agonist thereof to the subject, simultaneously or sequentially, thereby decreasing the calorie intake of the subject.
Patent CA-2473018-A1 (CA)
Title: Adjustable axle control
Inventor: HUMPAL RICHARD ALLEN
IPC: B60B35/10
Filed: 2004-07-06
Abstract: An activating portion on one section of an adjustable wheel assembly triggers a proximity switch on a vehicle such as a field sprayer to provide a signal indicative of wheel tread. The signal is sent to a controller which controls wheel tread adjustment. Two or more assemblies may be adjusted simultaneously reduce adjustment time. The operator control is located in the vehicle cab for entering wheel spacings, providing an indication of the actual spacing and individual wheel position, and providing error and warning messages. An interlock system prevents axle telescoping unless certain vehicle conditions are satisfied, such as the vehicle speed being below a preselected point and vehicle being in the field mode.
Patent CA-2474126-A1 (CA)
Inventor: LENORMAND REGIS
IPC: H01Q19/17
Filed: 2003-01-17
Abstract: L'invention concerne une antenne de réception pour les télécommunications par satellite. II s'agit d'une antenne active avec un réseau de sources élémentaires positionné au foyer d'un réflecteur focalisant. Selon l'invention, ledit réseau de sources est disposé sur une surface S concave et approximativement sphérique. Cette disposition permet une meilleure efficacité de l'optique, d'une part, et elle permet d'utiliser des duplexeurs de polarisation derrière la surface S d'autre part, pour augmenter l'efficacité spectrale de l'antenne.
Patent CA-2475552-A1 (CA)
Title: System and method for integrating management of resources between application services and applications
Inventor: ISAACS SCOTT
IPC: G06F17/00
Filed: 2004-07-22
Abstract: An application entity may be created and defined by a user at an application. Related service entities managed by different service applications may be matched and consolidated. The application entity may be associated with one or more related service entities. Metadata corresponding to the associated service entities may be provided to the application. Such metadata may enable the associated service entities to be managed from within the application.
Patent CA-2477705-A1 (CA)
Inventor: YOURIST SHELDON
IPC: B65D79/00
Filed: 2003-03-07
Abstract: L'invention concerne un contenant (110) moulé par soufflage et comprenant une base (112), une partie de corps fixée sur la base, une partie centrale (136) concave, fixée sur la partie de corps, un dôme (130) fixé sur la partie centrale et une finition (140). Le dôme comprend une pluralité de panneaux en retrait (134) disposés autour d'un périmètre du dôme et la finition comprend une ouverture (144). Une partie du dôme est située entre les panneaux en retrait et la partie centrale.
Patent CA-2478534-A1 (CA)
Title: Derives de benzimidazole n3 alkyles servant d'inhibiteurs de mek
Inventor: HURLEY T BRIAN
IPC: C07D235/08
Filed: 2003-03-13
Abstract: La présente invention concerne des composés de formule (I), dans laquelle W, t, R?1¿, R?2¿, R?7¿, R?9¿, R?10¿, R?11¿ et R?12¿ sont tels que définis dans la description, ainsi que des sels et des promédicaments de ceux-ci, acceptables d'un point de vue pharmaceutique. De tels composés sont des inhibiteurs de MEK et sont utilisés pour traiter des maladies hyperprolifératives, telles que le cancer et les inflammations, chez les mammifères. La présente invention concerne également un procédé d'utilisation de ces composés pour traiter des maladies hyperprolifératives chez les mammifères, ainsi que des compositions pharmaceutiques contenant ces composés.
Patent CA-2478805-A1 (CA)
Inventor: MORTENSON MARK G
IPC: A61K41/00
Filed: 2003-03-11
Abstract: This invention relates to novel methods for affecting, controlling and/or directing various reactions and/or reaction pathways or systems by exposing one or more components in a holoreaction system to at least one spectral energy pattern. In a first aspect of the invention, at least one spectral energy pattern can be applied to a reaction system. In a second aspect of the invention, at least one spectral energy conditioning pattern can be applied to a conditioning reaction system. The spectral energy conditioning pattern can, for example, be applied at a separate location from the reaction vessel (e.g., in a conditioning reaction vessel) or can be applied in (or to) the reaction vessel, but prior to other reaction system participants being introduced into the reaction vessel.
Patent CA-2479000-A1 (CA)
Title: Materiaux de membrane composite conducteurs d'ions contenant un phosphate de zirconium eventuellement modifie disperse dans une matrice polymere, procede de preparation de ce materiau et son utilisation
Inventor: PICA MONICA
IPC: C08K3/32
Filed: 2003-03-12
Abstract: L'invention concerne des matériaux de membrane composite comprenant un polymère rempli uniformément par un phosphate de zirconium, de préférence, un phosphate d'.alpha.-zirconium, ou des particules de sulfoarylènephosphonate de phosphate de zirconium. Ces matériaux sont, de préférence, préparés à partir d'une solution polymère et d'une dispersion colloïdale de phosphate d'.alpha.-zirconium ou de sulfoarylènephosphonate de phosphate de zirconium. Ces particules colloïdales sont introduites dans la solution polymère, de préférence, par mélange de la dispersion et de la solution ou au moyen d'un transfert de phase. Ce matériau de membrane s'obtient, de préférence, par suppression du solvant par évaporation ou au moyen d'un non-solvant approprié. En plus de ces matériaux de ces membranes composites et de leurs procédés de préparation, elle concerne l'utilisation de ces matériaux sous forme de membranes ionomères de haute performance à température élevée, en particulier, dans des piles à combustible à hydrogène ou à méthanol indirect, tout en présentant une diminution de la transition méthanol dans des piles à combustible à méthanol direct.
Patent CA-2479501-A1 (CA)
Inventor: BEAUDOIN ADRIEN
IPC: C12Q1/42
Filed: 2003-04-22
Abstract: Cette invention se rapporte à un procédé de criblage d'un composé utile dans le traitement d'une maladie ou d'un état se caractérisant par un trouble des cellules immunitaires, lesquelles expriment les enzymes NTPDases, ce procédé consistant à mettre en contact un composé candidat avec l'enzyme ecto-nucléoside triphosphate diphosphohydrolase (NTPDase), ce composé candidat étant sélectionné lorsque l'activité de cette enzyme NTPDase est réduite en présence du composé candidat par rapport à son activité en l'absence dudit composé. Un procédé pour inhiber l'activité des cellules immunitaires chez un mammifère consiste à cibler les cellules immunitaires avec une quantité efficace d'un inhibiteur de NTPDase. Un procédé pour prévenir ou réduire les risques de rejet de tissus ou d'organes transplantés consiste à administrer à cet animal une quantité efficace d'un inhibiteur de NTPDase.
Patent CA-2485585-A1 (CA)
Title: Unite de commande pour reguler la distribution d'un gaz combustible dans des unites de soupapes, en particulier pour des dispositifs chauffe-eau et unite de soupapes comprenant ladite unite de commande
Inventor: TREVISANATO NICOLA
IPC: F23N1/00
Filed: 2002-06-21
Abstract: L'invention concerne une unité de commande permettant de réguler la distribution d'un gaz combustible dans une unité de soupapes (2) du type comprenant des éléments de soupapes (4) pour couper l'arrivée de gaz, soumis à la commande opérationnelle d'une unité de sécurité magnétique (5) à thermocouple (10). L'unité de commande comprend un circuit électronique (12) monté de manière à assurer la connexion avec des éléments de détection (13), adaptés pour détecter la présence de vapeurs inflammables ou d'autres substances dangereuses, le circuit (12) étant alimenté par des éléments générateurs de courant électrique. Le circuit (12) comprend un commutateur (14) de type électronique agissant sur ledit circuit électrique (11), pour alimenter l'unité magnétique (5), de manière à couper le circuit et à actionner les éléments de soupape (4) pour fermer, en présence de vapeurs inflammables détectées par les éléments de détection (13).
Patent CA-2488287-A1 (CA)
Inventor: PAL BIKASH CHANDRA
IPC: A61K36/18
Filed: 2002-12-20
Abstract: The present invention relates to a new use of the compound chlorogenic acid isolated from the piper betel leaf extract or from any other sources for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia, and t he present invention also provides a pharmaceutical composition comprising chloregenic acid along with pharmaceutically acceptable additive for the treatment of acute and chronic myeloid leukemia and lymphoid leukemia.</SDOA B>
Patent CA-2490452-A1 (CA)
Inventor: TSUBAKI KAZUFUMI
IPC: A23L7/10
Filed: 2003-06-18
Abstract: La présente invention concerne une composition contenant du .beta.-glucane originaire d'un micro-organisme ou de basidiomycètes. L'utilisation de cette composition contenant du .beta.-glucane permet de disperser uniformément ce .beta.-glucane dans un aliment sans en dégrader la texture, le goût, etc.. Cette invention concerne aussi un nouveau micro-organisme capable de produire efficacement du .beta.-glucane qui possède une activité élevée et des qualités favorables, ce micro-organisme pouvant être utilisé pour obtenir le .beta.-glucane dans les conditions susmentionnées, à une vitesse de production élevée à partir de saccharides moins coûteux tels que du saccharose.
Patent CA-2490549-A1 (CA)
Title: Infusion device and method thereof
Inventor: PATTON CATHERINE C
IPC: A61M5/158
Filed: 2003-06-30
Abstract: The disclosures made herein relate to an infusion device (10) specifically adapted for syringe injections.  In one embodiment of the disclosures made herein, an infusion device comprises a body (12) including an accessible surface having a single inlet port (20) therein, an engagement surface (22) having a single outlet port (24) therein, a medication delivery channel (28) extending between the single inlet port (20) and the single outlet port (24), and an identification feature (36) on the accessible surface of the body (12) adjacent to the single inlet port (20). A cannula (14) is coupled to the body (12) at the single outlet port (24) and is adapted for receiving medication from the single outlet port (24) and transmitting the medication therethrough. Once the infusion device (10) is mounted on the patient, the patient may use a syringe (34) and injection needle (32) for receiving an injection of one or more medications via the infusion device.
Patent CA-2492230-A1 (CA)
Inventor: STANGE FRIEDRICH GERT
IPC: G05D1/08
Filed: 2003-07-18
Abstract: A method and apparatus are described for controlling the attitude of a vehicle (10) in a space having at least two opposed viewable regions (6, 7), each region being viewed by a respective first sensor (60, 70) for sensing a first frequency band of electromagnetic radiation and a respective second sensor (61, 71) for sensing a second frequency band of electromagnetic radiation, wherein respective first and second data sets from the first (60, 70) and second sensors (61, 71) for each regions (6, 7) are produced, these second data sets are subsequently modified (62, 72) and combined (63, 73) with the first data sets to form respective third data sets for each region (6, 7). The attitude of the vehicle (10) is then adjusted (40) until the third data sets are substantially equal.
Patent CA-2495885-A1 (CA)
Title: Procede de repartition aleatoire combinatoire et selective de polynucleotides
Inventor: SPANGENBERG OLIVER
IPC: C12N15/09
Filed: 2003-08-22
Abstract: L'invention concerne un procédé de répartition aléatoire combinatoire et sélective (SCR) de polynucléotides sur des sites spécifiques. Ce procédé consiste à préparer une séquence polynucléotidique à double brin, dotée d'au moins un site différent, et à répartir de manière aléatoire et sélective le polynucléotide sur les sites différents ou à proximité de ceux-ci, sans avoir à déterminer la position séquentielle du site différent.
Patent CA-2502890-A1 (CA)
Inventor: LORENCE ROBERT M
IPC: A61K35/76
Filed: 2003-11-03
Abstract: On utilise un virus à ARN à brins négatifs pour traiter les mammifères atteints de tumeurs carcinoïdes.
Patent CA-2504288-A1 (CA)
Inventor: RICHMOND SIMON NICHOLAS
IPC: B65D85/86
Filed: 2005-04-15
Abstract: A packaging (10) containing a product (11). The product (11) may be a solar powered light device (110). The packaging (10) includes a switch (23) that is operable to activate the product (11) while the product (11) is still within the packaging (10) so that a user may observe operation of the product (11) without removing the product (11) from the packaging (10).
Patent CA-2506236-A1 (CA)
Inventor: JABES DANIELA
IPC: A61K31/70
Filed: 2003-11-14
Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
Patent CA-2506504-A1 (CA)
Title: Treatment of lung cells with histone deacetylase inhibitors
Inventor: WIECH NORBERT L
IPC: A61K31/19
Filed: 2003-11-19
Abstract: Lung disease, such as cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), asthma or acute and chronic bronchitis, can be treated with an oxyamide-containing compound.
Patent CA-2507995-A1 (CA)
Inventor: LATHROP ROBERT
IPC: G01N35/10
Filed: 2003-12-19
Abstract: An automated staining apparatus (1) and a method for treating samples arranged on carrier means (7) is disclosed, in which portions of two or more selected reagents from a first station (2) containing the reagents are collected individually by means of a robot arm (20) handling a probe (10) and dispensed in a mixing station (9) of the apparatus. After mixing the reagents in the mixing station (9) , e.g. by shaking or rotating the mixing cup containing the reagents, the reagent mixture is applied to selected samples by means of the robot arm (20) and a probe.(10) .By providing a staining apparatus having an automated mixer integrated therein, staining or treatment processes requiring a mixture of unmixable reagents, such as a water based and an oil based reagent, or insoluble reagents, can be performed automatically instead of requiring human interaction or manual performance of some process steps in a much more automated process, and the quality of the staining process may be improved as a desired degree of mixing of reagents may be provided or an optimal application time window for a deteriorating mixture may be reached.
Patent CA-2515208-A1 (CA)
Inventor: KURODA SHUNICHI
IPC: A61K35/32
Filed: 2004-02-09
Abstract: La présente invention porte d'une manière générale sur un facteur de croissance osseuse et concerne en particulier des compositions renfermant NELL1, des articles fabriqués comprenant NELL1 ainsi que des méthodes d'utilisation de NELL1 pour induire la formation osseuse. Cette invention concerne également des méthodes d'expression et de purification de peptides NELL1 et NELL2.
Patent CA-2515682-A1 (CA)
Title: Method of producing a processing substrate
Inventor: LEBOEUF WILLIAM E
IPC: A47J47/00
Filed: 2004-02-11
Abstract: A method of creating a layer of a single use processing substrate includes the steps of extruding a polymeric sheet with a particulate substance dispersed therein, cooling the polymeric sheet with the particulate substance therein, removing the particulate substance from the polymeric sheet to form holes in the polymeric sheet, and attaching the polymeric sheet to an absorbent sheet.
Patent CA-2518125-A1 (CA)
Inventor: LUO LIFENG
IPC: B23K9/10
Filed: 2005-09-02
Abstract: A three stage power source for an electric arc welding process comprising an input stage having an AC input and a first DC output signal; a second stage in the form of an unregulated DC to DC converter having an input connected to the first DC output signal, a network of switches switched at a high frequency with a given duty cycle to convert the input into a first internal AC signal, an isolation transformer with a primary winding driven by the first internal high frequency AC signal and a secondary winding for creating a second internal high frequency AC signal and a rectifier to convert the second internal AC signal into a second DC output signal of the second stage, with a magnitude related to the duty cycle of the switches; and, a third stage to convert the second DC output signal to a welding output for welding wherein the input stage has a regulated DC to DC converter with a boost power switch having an active soft switching circuit.
Patent CA-2519930-A1 (CA)
Inventor: WEDGE STEPHEN ROBERT
IPC: A61P35/00
Filed: 2004-05-04
Abstract: The invention relates to the use of an anti-angiogenic agent in combination with an inhibitor of the Src family of non-receptor tyrosine kinases in the manufacture of a medicament for use in the substantially normotensive treatment in a warm-blooded mammal such as a human being of a disease state associated with angiogenesis, the Src kinase inhibitor being administered in an amount effective to counteract substantially the hypertension induced by the anti-angiogenic agent.
Patent CA-2521909-A1 (CA)
Title: Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
Inventor: BARDAT ANNIE
IPC: A61K47/26
Filed: 2004-04-08
Abstract: L'invention concerne une formulation stabilisante pour compositions d'immunoglobulines G comprenant un sucre alcoolique, la glycine et un détergent non ionique et qui est appropriée à la stabilisation de compositio ns d'immunoglobulines G sous forme liquide et sous forme lyophilisée. Elle concerne également une composition d'immunoglobulines G sous forme liquide o u sous forme lyophilisée comprenant ladite formulation stabilisante.
Patent CA-2522033-A1 (CA)
Title: Femoral neck fixation prosthesis
Inventor: CROFFORD THEODORE
IPC: A61F2/00
Filed: 2003-04-07
Abstract: A femoral neck fixation prosthesis and method of using same which reduces bo ne loss and the avoids the other shortcomings of the prior art by allowing the fixation of a stable femoral head replacement while reducing the amount of t he femur which must be reamed for the insertion of the prosthesis. The preferre d embodiment provides that the femoral head (110) is attached to a fixation prosthesis (110, 125, 130, 140) which extends coaxially through the canal of the femoral neck, into the femur, and is then attached to the opposite later al wall of the femur. In this manner, the prosthesis serves to imitate the original structure of the femoral neck. No other support members, either crosspins or arms extending into the length of the femur, are required.</SDO AB>